Review
Published on 12 Jul 2021
Clinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2021.693104
- 48,169 views
- 137 citations
30 articles related to "Hormone Receptor Hr"
Articles
Review
Published on 15 Mar 2017
Clinical Implications of ESR1 Mutations in Hormone Receptor-Positive Advanced Breast Cancer
in Women's Cancer
Frontiers in Oncology
doi 10.3389/fonc.2017.00026
- 29,396 views
- 90 citations
Review
Published on 04 Oct 2023
Treatment options for patients with hormone receptor-positive, HER2-negative advanced-stage breast cancer: maintaining cyclin-dependent kinase 4/6 inhibitors beyond progression
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1272602
- 4,956 views
- 4 citations
Review
Published on 10 Aug 2018
Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer
in Women's Cancer
Frontiers in Oncology
doi 10.3389/fonc.2018.00308
- 15,008 views
- 72 citations
Case Report
Published on 20 Aug 2025
Double trouble, managing bilateral inflammatory breast cancer: a case report
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1595513
- 2,752 views
Case Report
Published on 22 Feb 2021
Case Report: Long-Term Response to Pembrolizumab Combined With Endocrine Therapy in Metastatic Breast Cancer Patients With Hormone Receptor Expression
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2021.610149
- 7,280 views
- 11 citations
Original Research
Published on 02 Mar 2021
Linc00665 Can Predict the Response to Cisplatin-Paclitaxel Neoadjuvant Chemotherapy for Breast Cancer Patients
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2021.604319
- 3,635 views
- 12 citations
Case Report
Published on 27 Mar 2024
Case report: Primary CDK4/6 inhibitor and endocrine therapy in locally advanced breast cancer and its effect on gut and intratumoral microbiota
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1360737
- 5,763 views
- 4 citations
Original Research
Published on 05 Mar 2025
Predictive factors for outcome in HER2-low breast cancer patients after neoadjuvant chemotherapy
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1459444
- 1,955 views
Original Research
Published on 04 Apr 2025
Differences in treatment response and survival between HER2(2+)/FISH-positive and HER2(3+) breast cancer patients after dual-target neoadjuvant therapy: a matched case-control study
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1530793
- 2,676 views
- 2 citations
Systematic Review
Published on 28 Nov 2025
The impact of BRCA mutation and hormone receptor status on the outcomes of fertility preservation in breast cancer patients: a systematic review and meta-analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1639420
- 1,071 views
Original Research
Published on 11 Mar 2025
The value of intratumoral and peritumoral radiomics features based on multiparametric MRI for predicting molecular staging of breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1379048
- 2,489 views
- 2 citations
Original Research
Published on 17 Nov 2025
Assessment of the efficacy of various neoadjuvant anti-HER2 targeted therapies combined with chemotherapy for HER2-positive breast cancer in the real-world setting and development of a predictive model for pathological complete response
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1673810
- 1,502 views
Original Research
Published on 26 Aug 2022
Characteristics and survival in bone metastatic breast cancer patients with different hormone receptor status: A population-based cohort study
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.977226
- 26,287 views
- 20 citations
Original Research
Published on 17 Jan 2022
In Real Life, Low-Level HER2 Expression May Be Associated With Better Outcome in HER2-Negative Breast Cancer: A Study of the National Cancer Center, China
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2021.774577
- 11,165 views
- 99 citations
Original Research
Published on 02 Dec 2020
Breast Subtypes and Prognosis of Breast Cancer Patients With Initial Bone Metastasis: A Population-Based Study
in Women's Cancer
Frontiers in Oncology
doi 10.3389/fonc.2020.580112
- 12,029 views
- 51 citations